After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months …